Holen Sie sich die Stockscreener-App
70.22
2.17%
1.49
Vorhandelsmarkt:
70.60
0.38
+0.54%
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
JPMorgan Chase Reduces Stake in AnaptysBio Biotech Firm - National Today
AnaptysBio, Inc. $ANAB Shares Sold by JPMorgan Chase & Co. - MarketBeat
Aug Macro: Can AnaptysBio Inc reach all time highs this year2026 Trading Recap & Real-Time Price Movement Reports - baoquankhu1.vn
Anaptys to spin-off First Tracks Biotherapeutics, announces $100M buyback - MSN
ANAPTYSBIO INC- W/I (ANABV) Stock Chart - ChartMill
ANABV Technical Analysis | Trend, Signals & Chart Patterns | ANAPTYSBIO INC- W/I (NASDAQ:ANABV) - ChartMill
AnaptysBio stock hits 52-week high at 68.46 USD By Investing.com - Investing.com Australia
AnaptysBio (NASDAQ:ANAB) Hits New 1-Year HighTime to Buy? - MarketBeat
AnaptysBio stock hits 52-week high at 68.46 USD - Investing.com
Equity in earnings of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Pretax income of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Total equity of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Total assets of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Net debt of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Balance Sheet – NASDAQ:ANABV - TradingView — Track All Markets
After tax other income/expense of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Behavioral Patterns of ANAB and Institutional Flows - Stock Traders Daily
ANABV Price Today: AnaptysBio, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
Return on assets % of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Asset turnover of AnaptysBio, Inc. – NASDAQ:ANABV - tradingview.com
Quick ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Book value per share of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView
Net current asset value per share of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Current ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Enterprise value to EBITDA ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Debt to assets ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Price to cash flow ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Price to book ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
EBITDA margin % of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio: Upside Constrained By Undifferentiated Data, Legal Uncertainties - Seeking Alpha
Debt to equity ratio of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Enterprise value of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Statistics – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Earnings and Revenue – NASDAQ:ANABV - TradingView — Track All Markets
ANABV Price Today: AnaptysBio, Inc. Stock Price, Quote & Chart - MEXC
ANABV interactive stock chart | ANAPTYSBIO INC stock - Yahoo Finance Singapore
AnaptysBio, Inc. Income Statement – NASDAQ:ANABV - TradingView — Track All Markets
Free float of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
Basic earnings per share (basic EPS) of AnaptysBio, Inc. – NASDAQ:ANABV - TradingView — Track All Markets
AnaptysBio, Inc. Dividends – NASDAQ:ANABV - TradingView — Track All Markets
Trade Alert: Independent Director Of AnaptysBio John Schmid Has Sold Stock - simplywall.st
AnaptysBio, Inc.: Target Price Consensus and Analysts Recommendations | ANABV | US0327242055 - marketscreener.com
Price performance - Yahoo Finance Singapore
Risk On: Will AnaptysBio Inc face regulatory challengesPortfolio Return Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
AnaptysBio (NASDAQ:ANAB) Trading Up 7.6%Still a Buy? - MarketBeat
AnaptysBio, Inc. (ANAB) stock price, news, quote and history - Yahoo Finance UK
Spin-off Imminent At AnaptysBio - San Diego Business Journal
AnaptysBio, Inc. Common Stock When Issued (ANABV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB) - The Globe and Mail
Assessing AnaptysBio (ANAB) Valuation After New US$100 Million Buyback And Cancelled Equity Offerings - Yahoo Finance
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $69 - Moomoo
Director Susannah Gray at AnaptysBio (ANAB) submits initial Form 3 - Stock Titan
ANAB Technical Analysis & Stock Price Forecast - Intellectia AI
ANABV|AnaptysBio Ord Shs|| - TradingKey
ANABV|AnaptysBio Ord Shs|Price:44.500|Chg%:3.06 - TradingKey
First Tracks Biotherapeutics to be spun off from AnaptysBio, Nasdaq trading set for April 20 By Investing.com - Investing.com South Africa
First Tracks Biotherapeutics to be spun off from AnaptysBio, Nasdaq trading set for April 20 - Investing.com
Insider Selling: AnaptysBio (NASDAQ:ANAB) Director Sells 20,645 Shares of Stock - MarketBeat
Aug Highlights: Can AnaptysBio Inc grow without external funding2026 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn
AnaptysBio Insider Sold Shares Worth $1,158,451, According to a Recent SEC Filing - marketscreener.com
Director John Schmid Sells 20,645 Shares of AnaptysBio Inc (ANAB) - GuruFocus
Anaptysbio director Schmid sells $1.16 million in stock By Investing.com - Investing.com Canada
[Form 4] ANAPTYSBIO, INC Insider Trading Activity - Stock Titan
AnaptysBio Director Sold Shares Worth Over $1.1M - TradingView
Aug Volume: Is AnaptysBio Inc stock a good dividend stock2026 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):